Skip to content
Evigrade
MinorPlant alkaloid (isoquinoline), food supplement×Digestives. Multienzyme preparations

Updated · Methodology

Mechanism

Pancreatin acts only in the gut lumen: the enzymes are not absorbed intact but are digested like other proteins to peptides and amino acids (Kreon SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 5.2). No interaction studies have been performed with pancreatin (Kreon SmPC, AEMPS, section 4.5). Berberine is a plant alkaloid. It is not authorised as a medicine in Spain and is sold as a food supplement, usually at 250–500 mg two or three times a day (LiverTox, NIH). In healthy men, berberine 300 mg three times a day for two weeks inhibited CYP2D6, CYP2C9 and CYP3A4: exposure to midazolam, a CYP3A4 substrate, rose by 40% (Guo et al., 2012). Pancreatin does not reach the bloodstream and does not act on liver enzymes. This combination has not been studied, and no mechanism by which berberine and pancreatin would affect each other is known.

Symptoms

No symptoms caused by this combination have been described. Fibrosing colonopathy has been reported in people with cystic fibrosis taking high doses of pancreatin, and anaphylactic reactions are rare. Chewing the capsules or holding them in the mouth can irritate the oral mucosa (Kreon SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.4). Berberine's adverse effects are usually mild and transient: nausea, bloating, diarrhoea or constipation. In controlled trials they were no more frequent than with placebo, and no liver injury from berberine has been described (LiverTox, NIH).

Management

The combination can be used and no dose change is needed. There are no data on an interaction, and no mechanism that would cause one is known (Kreon SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, sections 4.5 and 5.2). Pancreatin capsules should not be chewed or held in the mouth. Unusual or changing abdominal symptoms are assessed to rule out fibrosing colonopathy, especially in people with cystic fibrosis taking more than 10 000 lipase units per kilogram per day (Kreon SmPC, AEMPS, section 4.4). Because berberine inhibits CYP2D6, CYP2C9 and CYP3A4, bear in mind that it may raise the levels of other drugs metabolised by these enzymes (Guo et al., 2012).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Berberine

Other interactions with Pancreatin